Search research articles
Contact Us
Filters
Showing results (41-50 of 52) with videos related to
Page
of 6
Sort By:
Development (Cambridge, England)
|
May 26, 2011
The MADS box transcription factor MEF2C regulates melanocyte development and is a direct transcriptional target and partner of SOX10
Pooja Agarwal, Michael P Verzi, Thuyen Nguyen, et al.
The Journal of Investigative Dermatology
|
October 4, 2019
MicroRNA Ratios Distinguish Melanomas from Nevi
Rodrigo Torres, Ursula E Lang, Miroslav Hejna, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 29, 2011
Targeting protein-trafficking pathways alters melanoma treatment sensitivity
Zhi-ming Huang, Milka Chinen, Philip J Chang, et al.
NPJ Digital Medicine
|
January 22, 2021
Stress testing reveals gaps in clinic readiness of image-based diagnostic artificial intelligence models
Albert T Young, Kristen Fernandez, Jacob Pfau, et al.
JAMA Dermatology
|
February 28, 2017
Outcomes of Melanoma In Situ Treated With Mohs Micrographic Surgery Compared With Wide Local Excision
Adi Nosrati, Jacqueline G Berliner, Shilpa Goel, et al.
Allergy
|
January 24, 2024
Impact of climate change on atopic dermatitis: A review by the International Eczema Council
Sheng-Pei Wang, Nicholas Stefanovic, Raquel L Orfali, et al.
Elife
|
November 23, 2021
BRAF<sup>V600E</sup> induces reversible mitotic arrest in human melanocytes via microrna-mediated suppression of AURKB
Andrew S McNeal, Rachel L Belote, Hanlin Zeng, et al.
The Journal of Investigative Dermatology
|
April 16, 2014
Basis for enhanced barrier function of pigmented skin
Mao-Qiang Man, Tzu-Kai Lin, Juan L Santiago, et al.
JAMA Dermatology
|
January 6, 2021
Dermoscopy Proficiency Expectations for US Dermatology Resident Physicians: Results of a Modified Delphi Survey of Pigmented Lesion Experts
Lauren J Fried, Andrea Tan, Elizabeth G Berry, et al.
Cancer
|
October 4, 2018
Chemoprevention agents for melanoma: A path forward into phase 3 clinical trials
Joanne M Jeter, Tawnya L Bowles, Clara Curiel-Lewandrowski, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 52) with videos related to
Sort By:
Page
of 6
Development (Cambridge, England)
|
May 26, 2011
The MADS box transcription factor MEF2C regulates melanocyte development and is a direct transcriptional target and partner of SOX10
Pooja Agarwal, Michael P Verzi, Thuyen Nguyen, et al.
The Journal of Investigative Dermatology
|
October 4, 2019
MicroRNA Ratios Distinguish Melanomas from Nevi
Rodrigo Torres, Ursula E Lang, Miroslav Hejna, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 29, 2011
Targeting protein-trafficking pathways alters melanoma treatment sensitivity
Zhi-ming Huang, Milka Chinen, Philip J Chang, et al.
NPJ Digital Medicine
|
January 22, 2021
Stress testing reveals gaps in clinic readiness of image-based diagnostic artificial intelligence models
Albert T Young, Kristen Fernandez, Jacob Pfau, et al.
JAMA Dermatology
|
February 28, 2017
Outcomes of Melanoma In Situ Treated With Mohs Micrographic Surgery Compared With Wide Local Excision
Adi Nosrati, Jacqueline G Berliner, Shilpa Goel, et al.
Allergy
|
January 24, 2024
Impact of climate change on atopic dermatitis: A review by the International Eczema Council
Sheng-Pei Wang, Nicholas Stefanovic, Raquel L Orfali, et al.
Elife
|
November 23, 2021
BRAF<sup>V600E</sup> induces reversible mitotic arrest in human melanocytes via microrna-mediated suppression of AURKB
Andrew S McNeal, Rachel L Belote, Hanlin Zeng, et al.
The Journal of Investigative Dermatology
|
April 16, 2014
Basis for enhanced barrier function of pigmented skin
Mao-Qiang Man, Tzu-Kai Lin, Juan L Santiago, et al.
JAMA Dermatology
|
January 6, 2021
Dermoscopy Proficiency Expectations for US Dermatology Resident Physicians: Results of a Modified Delphi Survey of Pigmented Lesion Experts
Lauren J Fried, Andrea Tan, Elizabeth G Berry, et al.
Cancer
|
October 4, 2018
Chemoprevention agents for melanoma: A path forward into phase 3 clinical trials
Joanne M Jeter, Tawnya L Bowles, Clara Curiel-Lewandrowski, et al.
Page
of 6